Amphastar Pharmaceuticals, Inc.s Prospects Need A Boost To Lift Shares
| AMPH Stock | USD 39.45 1.40 3.43% |
Under 62% of Amphastar's investor base is looking to short. The analysis of overall sentiment of trading Amphastar P stock suggests that many investors are alarmed at this time. Amphastar's investing sentiment shows overall attitude of investors towards Amphastar P.
Amphastar |
With a price-to-earnings ratio of 12.9x Amphastar Pharmaceuticals, Inc. may be sending...
Read at simplywall.st
 |
Amphastar Fundamental Analysis
We analyze Amphastar's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amphastar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amphastar based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Amphastar is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Amphastar P Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amphastar stock to make a market-neutral strategy. Peer analysis of Amphastar could also be used in its relative valuation, which is a method of valuing Amphastar by comparing valuation metrics with similar companies.
Peers
Amphastar Related Equities
| IRWD | Ironwood Pharmaceuticals | 12.14 | ||||
| PAHC | Phibro Animal | 2.54 | ||||
| PCRX | Pacira BioSciences, | 1.98 | ||||
| EVO | Evotec SE | 1.62 | ||||
| COLL | Collegium Pharmaceutical | 1.40 | ||||
| SUPN | Supernus Pharmaceuticals | 0.87 | ||||
| ANIP | ANI Pharmaceuticals | 0.71 | ||||
| PBH | Prestige Brand | 0.16 | ||||
| ALKS | Alkermes Plc | 0.33 | ||||
| NBIX | Neurocrine Biosciences | 0.36 | ||||
| EOLS | Evolus | 1.90 |
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |